RLI's Q4 Earnings Beat Estimates on Strong Net Investment Income — Positive

RLI   Zacks Investment Research — January 22, 2026

RLI's Q4 earnings reflect higher premiums, improved investment income, reduced expenses, and solid underwriting income.

image for news RLI's Q4 Earnings Beat Estimates on Strong Net Investment Income

TrustCo Bank Corp NY (TRST) Q4 2025 Earnings Call Transcript — Neutral

TRST   Seeking Alpha — January 22, 2026

TrustCo Bank Corp NY (TRST) Q4 2025 Earnings Call Transcript

image for news TrustCo Bank Corp NY (TRST) Q4 2025 Earnings Call Transcript

GURU Organic Energy Corp. (GURU:CA) Q4 2025 Earnings Call Transcript — Neutral

GUROF  GURU   Seeking Alpha — January 22, 2026

GURU Organic Energy Corp. (GURU:CA) Q4 2025 Earnings Call Transcript

image for news GURU Organic Energy Corp. (GURU:CA) Q4 2025 Earnings Call Transcript

Teledyne's Momentum Makes Me Comfortable Buying At A Premium — Positive

TDY   Seeking Alpha — January 22, 2026

Teledyne Technologies Incorporated delivered strong Q4 results, with EPS of $6.30 beating by $0.47 and revenue up 7.3% year-over-year. TDY's momentum is driven by robust defense demand, improving commercial activity, and record sales in autonomous and marine instrumentation. Digital Imaging led growth, especially in infrared components for unmanned systems, with segment margins improving to 22.6% for 2025.

image for news Teledyne's Momentum Makes Me Comfortable Buying At A Premium

LOS ANGELES--(BUSINESS WIRE)---- $NATH--NATH Investors Have the Opportunity to Join Investigation of Nathan's Famous, Inc. with the Schall Law Firm.

image for news NATH Investors Have the Opportunity to Join Investigation of Nathan's Famous, Inc. With the Schall Law Firm

What's Going On With Rocket Lab Stock Today — Neutral

RKLB   Benzinga — January 22, 2026

Rocket Lab Corporation (NASDAQ: RKLB) shares are trading lower on Thursday. The company disclosed that it completed its first launch of 2026 and its 80th Electron mission overall.

image for news What's Going On With Rocket Lab Stock Today

Moderna is curbing investment in vaccine trials due to US backlash — Negative

MRNA   Bloomberg Markets and Finance — January 22, 2026

Moderna CEO Stephane Bancel said the company doesn't plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from US officials https://bloom.bg/3LNHufg

image for news Moderna is curbing investment in vaccine trials due to US backlash

Best Growth Stocks to Buy for January 22nd — Positive

BNPQY  CASY  PAX   Zacks Investment Research — January 22, 2026

CASY, PAX and BNPQY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 22, 2026.

image for news Best Growth Stocks to Buy for January 22nd

These Analysts Increase Their Forecasts On Prologis After Q4 Results — Neutral

PLD   Benzinga — January 22, 2026

Prologis Inc. (NYSE: PLD) reported weak revenue for its fourth quarter on Wednesday.

image for news These Analysts Increase Their Forecasts On Prologis After Q4 Results

Old National Receives 2026 Trust in Banking Award — Neutral

ONB   GlobeNewsWire — January 22, 2026

EVANSVILLE, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) – Old National Bancorp (“Old National”) has been named the recipient of the “Customer Confidence Award” as part of Quavo's 2nd annual Trust in Banking Awards for 2026.

image for news Old National Receives 2026 Trust in Banking Award

AMD's stock is on a hot streak not seen in six years — Positive

AMD   Market Watch — January 22, 2026

Ahead of Intel's earnings later on Thursday, AMD's stock is riding the broad excitement over central processing units for AI servers.

image for news AMD's stock is on a hot streak not seen in six years

Tesla Gears Up to Report Q4 Earnings: Here's What to Expect — Positive

TSLA   Zacks Investment Research — January 22, 2026

While weak EV sales are expected to dent TSLA's Q4 results, its booming energy storage business should be a bright spot.

image for news Tesla Gears Up to Report Q4 Earnings: Here's What to Expect

Is the Options Market Predicting a Spike in Ally Financial Stock? — Neutral

ALLY   Zacks Investment Research — January 22, 2026

Investors need to pay close attention to ALLY stock based on the movements in the options market lately.

image for news Is the Options Market Predicting a Spike in Ally Financial Stock?

SMCI's Server and Storage Segmental Revenues Surge: What Lies Ahead? — Positive

SMCI   Zacks Investment Research — January 22, 2026

Super Micro Computer's server and storage revenues jump 50.2% YoY to $21.31B in fiscal 2025, fueled by AI servers, rack-scale expansion and a $36 billion FY26 outlook.

image for news SMCI's Server and Storage Segmental Revenues Surge: What Lies Ahead?

AT&T: You Don't Need A Rerating To Win Here — Neutral

T   Seeking Alpha — January 22, 2026

AT&T (T) offers high yield and stability after a ~20% correction, with downside appearing mechanically contained and pessimism already priced in. ~$16b guided FCF supports ~2x dividend coverage, allowing deleveraging and absorbing current operational and capital cost pressures without threatening income stability. ARPU pressure, higher promotions, and modest churn reflect competitive maturity, while margins, service revenues, and convergence trends remain intact.

image for news AT&T: You Don't Need A Rerating To Win Here

AST SpaceMobile (ASTS) Stock: Which Comes First, $50 or $150? — Positive

ASTS   24/7 Wall Street — January 22, 2026

With new technologies come risky but promising investment opportunities. A case in point is AST SpaceMobile (NASDAQ:ASTS) stock, which just demonstrated its susceptibility to double-digit price moves.

image for news AST SpaceMobile (ASTS) Stock: Which Comes First, $50 or $150?

Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential — Positive

AMGN   Seeking Alpha — January 22, 2026

Amgen Inc. is rated a Buy, driven by robust pipeline prospects and the transformative potential of its obesity drug candidate MariTide. Recent AMGN performance includes 12% revenue growth in Q3 2025, upwardly revised 2025 guidance, and healthy operating margins near 30%. Patent expiries will pressure legacy products, but new launches and biosimilars are expected to offset declines, with pipeline assets potentially accelerating growth post-2026.

image for news Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential

NEW ORLEANS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against CoreWeave, Inc. (NasdaqGS: CRWV), if they purchased or otherwise acquired the Company's securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

image for news CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. - CRWV

Trump's Nuclear Nod: 3 Discounted Stocks Primed for a 2026 Breakout — Positive

NNE  OKLO  SMR   24/7 Wall Street — January 22, 2026

President Donald Trump addressed the World Economic Forum in Davos yesterday, where he praised nuclear energy for its safety improvements and affordability.

image for news Trump's Nuclear Nod: 3 Discounted Stocks Primed for a 2026 Breakout

Mobileye quarterly earnings miss estimates, shares slide — Negative

MBLY   Proactive Investors — January 22, 2026

Mobileye (NASDAQ:MBLY) shares fell more than 3% after the autonomous driving technology company reported fourth quarter results that missed Wall Street expectations on earnings, even as revenue came in above forecasts. The company reported adjusted earnings per share of $0.06 for the fourth quarter of 2025, well below the $0.24 analysts had expected.

image for news Mobileye quarterly earnings miss estimates, shares slide